Laurus Labs is currently trading at Rs. 375.75, up by 3.80 points or 1.02% from its previous closing of Rs. 371.95 on the BSE.
The scrip opened at Rs. 375.75 and has touched a high and low of Rs. 379.35 and Rs. 374.75 respectively. So far 0.17 lakh shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 377.30 on 14-Jan-2021 and a 52 week low of Rs. 61.90 on 24-Mar-2020.
Last one week high and low of the scrip stood at Rs. 379.35 and Rs. 352.50 respectively. The current market cap of the company is Rs. 19958.93 crore.
The promoters holding in the company stood at 28.73%, while Institutions and Non-Institutions held 24.00% and 47.27% respectively.
Laurus Labs has completed acquisition of 72.55% stake in Richcore Lifesciences. With this transaction Richcore Lifesciences has become a subsidiary company of Laurus Labs.
Earlier, the company had signed definitive agreements to acquire a majority stake in Richcore Lifesciences (Richcore). Richcore, a fast-growing biotech company based in Bengaluru with its advanced R&D and manufacturing facilities, develops and manufactures biotech products critical for manufacturing biological drugs.
Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1672.80 |
| Dr. Reddys Lab | 1238.00 |
| Cipla | 1238.25 |
| Zydus Lifesciences | 942.95 |
| Lupin | 2333.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: